Search

everythinglearnresearchcommunity

for

Search:↓

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Many children with alopecia areata also have other autoimmune diseases.

Red blood cell folate levels are reliable indicators of long-term folate status in alopecia areata patients.

Certain scalp tissue features can predict how well alopecia areata responds to steroid injections.

Both treatments help with hair regrowth in alopecia areata, but azathioprine has milder side effects than betamethasone.

Melatonin may help reduce the needed dose of prednisolone and improve hair growth in alopecia areata patients.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Alopecia areata, a common autoimmune hair loss condition, often runs in families.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Current treatments for alopecia show no significant long-term benefits.

Low iron levels may be linked to some types of hair loss in women.

Minoxidil works better for female hair loss, but cyproterone reduces scalp oiliness and causes menstrual issues.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Alopecia in captive rhesus macaques is affected by season, sex, age, housing, and stress, with complex links between stress hormones and hair loss.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Stem cell therapy may help treat tough hair loss cases.